Fig. 2: CD8+ T-cell subpopulations in the lung. | npj Vaccines

Fig. 2: CD8+ T-cell subpopulations in the lung.

From: Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus

Fig. 2

Balb/c mice were immunized as described before and lymphocytes from lungs were examined 36 days post boost. Antigen experienced CD8+ T-cells were identified by F85-93-specific pentamer staining and intravascular (iv) CD45 pan staining. CD45-labelled cells (iv+) were defined as circulating and iv protected (iv-) as tissue resident memory cells. a The absolute number of F85-93+ CD8+ with the relative contribution of iv+ and iv- cells was summarized for each group. Statistical analysis was performed over whole population. b Within the iv+ F85-93+ CD8+ population central memory T-cells (TCM; CD127+KLRG1-CD69-CD103-), effector T-cells (TEFF; CD127-KLRG1+) and effector memory T-cells (TEM; CD127+KLRG1+) were determined, whereas within the iv- population tissue resident memory T-cells (TRM; KLRG1-CD103+CD69+ or KLRG1-CD103+CD69- or KLRG1-CD103-CD69+) were defined100. Bars represent mean values with +SEM; naive n = 3, rAd5 (i.n.) n = 5, other groups n = 6. Data were analysed by one-way ANOVA followed by Tukey´s multiple comparison test. Statistically significant differences were indicated only among the used vaccine vectors within the intranasal resp. intramuscular group (*p < 0.05; **p < 0.005).

Back to article page